Companies · Medical Devices
Cape Town · Africa · Medical Devices · founded 2020
Diligence memoA one-page analyst read on AI Diagnostics — recommendation, valuation, rhythm, risks.→AI Diagnostics looks fair against its niche peers and is active on financing cadence.
Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the medical devices sector profile.
Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.
No named principal in this company's public records yet — see all operators below.
AI Diagnostics is one of 233 Medical Devices companies tracked from Cape Town, Africa, on record since 2020. By capital raised it ranks mid-pack (ahead of 69% of sector peers), and mid-pack by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
SA med-tech company AI Diagnostics raises $5.2m to accelerate AI-powered TB screening 0 By Tom Jackson on April 17, 2026 News , Southern Africa South African med-tech company AI Diagnostics has raised ZAR85 million (US$5.2 million) in funding to advance the use of its proprietary hardware and AI software in combatting the tuberculosis (TB) epidemic. Founded in 2020, the Cape Town-based AI Diagnostics develops accessible, early screening tools that empower frontline healthcare workers.
SA med-tech company AI Diagnostics raises $5.2m to accelerate AI-powered TB screening 0 By Tom Jackson on April 17, 2026 News , Southern Africa South African med-tech company AI Diagnostics has raised ZAR85 million (US$5.2 million) in funding to advance the use of its proprietary hardware and AI software in combatting the tuberculosis (TB) epidemic. Founded in 2020, the Cape Town-based AI Diagnostics develops accessible, early screening tools that empower frontline healthcare workers.
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.
Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 33%.
Round size and date are reported; the stage label is inferred from round size (latest is Series A — a $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the medical devices sector profile. Directional, not a quoted figure.
Not enough modeled valuation points to chart a trajectory.
Benchmarked against 233 companies in Medical Devices. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 69% of sector peers (real $). Modeled value above 54% of peers (estimate).
A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #5 of 10.
| Company | Stage | Raised · real | Value · est | vs peer med. |
|---|---|---|---|---|
| Curadel Surgical Innovations, Inc. | Series A | $26.0M | $44.1M | 4.27× |
| Gestalt Diagnostics, LLC | Series A | $9.6M | $25.2M | 2.44× |
| ClearCut Surgical, Inc. | Series A | $4.5M | $15.1M | 1.47× |
| Bayou Surgical, Inc. | Series A | $13.2M | $14.8M | 1.43× |
| AI Diagnostics this company | Series A | $5.2M | $12.7M | 1.23× |
| NexEos Diagnostics, Inc. | Series A | $25.7M | $7.9M | 0.77× |
| ReadySet Surgical, Inc. | Series A | $9.9M | $7.6M | 0.74× |
| Black Light Surgical, Inc. | Series A | $12.9M | $6.9M | 0.66× |
| EDGe Surgical, Inc. | Series A | $10.2M | $3.6M | 0.35× |
| Surgical Center of Greensboro, LLC | Series A | $12.4M | $2.9M | 0.28× |
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| Series A | $5.2M | 2026-04-17 | $23.6M | $12.7M | 45% |
Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
AI Diagnostics is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
| Company | Sector | Stage | Raised · real | Value · est | Why similar |
|---|---|---|---|---|---|
| CAIRA Surgical Corp | Medical Devices | Series A | $5.2M | $85.3M | same sector · same stage |
| Allotrope Medical Inc. | Medical Devices | Series A | $5.0M | $93.5M | same sector · same stage |
| Trilliant Surgical, LLC | Medical Devices | Series A | $5.7M | $17.4M | same sector · same stage |
| Thunder Road Surgical, Llc | Medical Devices | Series A | $5.8M | $62.7M | same sector · same stage |
| ClearCut Surgical, Inc. | Medical Devices | Series A | $4.5M | $15.1M | same sector · same stage |
| Hyperion Surgical, Inc. | Medical Devices | Series A | $6.0M | $38.7M | same sector · same stage |
| Acera Surgical, Inc. | Medical Devices | Series A | $6.2M | $123.6M | same sector · same stage |
| Juno Diagnostics, Inc. | Medical Devices | Series A | $6.3M | $107.8M | same sector · same stage |
Public records name issuer insiders, not the funds in a round — these investor links come from corroborating sources.
| Firm | Round | Confidence |
|---|---|---|
| Africa Health Ventures | Series A | 55% |
| Global Innovation Fund | Series A | 55% |
| Steele Foundation | Series A | 55% |
See where AI Diagnostics sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at AI Diagnostics, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.